| 1 |
Hertzog_2016 |
New Interferons |
Hertzog, Paul J.; Bourke, Nollaig M.; de Weerd, Nicole A.; Mangan, Niamh E. |
2016 |
2016-12-31 |
PMC |
N |
PMC7151816 |
|
10.1016/b978-0-12-374279-7.10007-4 |
5g1waed3 |
0.768117 |
Dixit_2013, Carlin_2017, Pervolaraki_2017, Schoggins_2011 |
Lasfar_2011, Egli_2014, Cohen_2016 |
| 2 |
Pott_2017 |
Type I and III Interferon in the Gut: Tight Balance between Host Protection and Immunopathology |
Pott, Johanna; Stockinger, Silvia |
2017 |
2017-03-14 |
COMM-USE |
N |
PMC5348535 |
28352268.0 |
10.3389/fimmu.2017.00258 |
ma7tsm68 |
0.630667 |
Pervolaraki_2017, Lester_2014, López_2011, Zhao_2009 |
Carrero_2013 |
| 3 |
Andreakos_2017 |
Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract |
Andreakos, Evangelos; Salagianni, Maria; Galani, Ioanna E.; Koltsida, Ourania |
2017 |
2017-09-29 |
COMM-USE |
N |
PMC5626824 |
29033947.0 |
10.3389/fimmu.2017.01232 |
fr0x6obj |
0.619575 |
Lester_2014, Bermejo-Jambrina_2018, Dixit_2013 |
Egli_2014, Carrero_2013 |
| 4 |
Antonelli_2015 |
Twenty-five years of type I interferon-based treatment: A critical analysis of its therapeutic use |
Antonelli, Guido; Scagnolari, Carolina; Moschella, Federica; Proietti, Enrico |
2015 |
2015-04-30 |
PMC |
N |
PMC7108252 |
25578520.0 |
10.1016/j.cytogfr.2014.12.006 |
9b11c0od |
0.612930 |
Schoggins_2011, Seo_Y_2010, Scagnolari_2018, Pervolaraki_2017 |
Egli_2014 |
| 5 |
Hemann_2017 |
Interferon Lambda Genetics and Biology in Regulation of Viral Control |
Hemann, Emily A.; Gale, Michael; Savan, Ram |
2017 |
2017-12-06 |
COMM-USE |
N |
PMC5723907 |
29270173.0 |
10.3389/fimmu.2017.01707 |
nf8dxwra |
0.609687 |
Pervolaraki_2017, López_2011, Schoggins_2011 |
Egli_2014, Carrero_2013 |
| 6 |
Pervolaraki_2017 |
Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut |
Pervolaraki, Kalliopi; Stanifer, Megan L.; Münchau, Stephanie; Renn, Lynnsey A.; Albrecht, Dorothee; Kurzhals, Stefan; Senís, Elena; Grimm, Dirk; Schröder-Braunstein, Jutta; Rabin, Ronald L.; Boulant, Steeve |
2017 |
2017-04-21 |
COMM-USE |
N |
PMC5399069 |
28484457.0 |
10.3389/fimmu.2017.00459 |
abpge1fb |
0.574699 |
Dixit_2013, Lester_2014, López_2011 |
Carrero_2013, Chen_2019 |
| 7 |
Cohen_2016 |
Microbial pathogenesis and type III interferons |
Cohen, Taylor S.; Parker, Dane |
2016 |
2016-06-30 |
None |
N |
PMC4899229 |
26987613.0 |
10.1016/j.cytogfr.2016.02.005 |
9iyduxfl |
0.558275 |
Lester_2014, Bermejo-Jambrina_2018, Dixit_2013 |
Carrero_2013, Egli_2014 |
| 8 |
O'Brien_2014 |
IFN-λ4: The Paradoxical New Member of the Interferon Lambda Family |
O'Brien, Thomas R.; Prokunina-Olsson, Ludmila; Donnelly, Raymond P. |
2014 |
2014-11-01 |
PMC |
N |
PMC4217005 |
24786669.0 |
10.1089/jir.2013.0136 |
dnefxuc7 |
0.553260 |
Ban_J_2018, Mar_K_2018 |
Egli_2014, Hamming_2013 |
| 9 |
Chevaliez_2009 |
Interferons and Their Use in Persistent Viral Infections |
Chevaliez, Stéphane; Pawlotsky, Jean-Michel |
2009 |
2009-01-01 |
PMC |
N |
PMC7114994 |
19048202.0 |
10.1007/978-3-540-79086-0_8 |
1e1rzm02 |
0.551752 |
|
Wang_2012, Carrero_2013 |
| 10 |
Hamming_2013 |
Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses |
Hamming, Ole J; Terczyńska-Dyla, Ewa; Vieyres, Gabrielle; Dijkman, Ronald; Jørgensen, Sanne E; Akhtar, Hashaam; Siupka, Piotr; Pietschmann, Thomas; Thiel, Volker; Hartmann, Rune |
2013 |
2013-10-29 |
PMC |
N |
PMC3844954 |
24169568.0 |
10.1038/emboj.2013.232 |
607px154 |
0.550996 |
Ban_J_2018, Meyerson_2017, Ashour_2010 |
Bruening_2017, O'Brien_2014, Egli_2014 |
| 11 |
Lasfar_2011 |
Interferon Lambda: A New Sword in Cancer Immunotherapy |
Lasfar, Ahmed; Abushahba, Walid; Balan, Murugabaskar; Cohen-Solal, Karine A. |
2011 |
2011-12-06 |
COMM-USE |
N |
PMC3235441 |
22190970.0 |
10.1155/2011/349575 |
d3p9nbgq |
0.549920 |
Pervolaraki_2017, López_2011, Schoggins_2011, Hemann_2017 |
Egli_2014 |
| 12 |
Chung_2020 |
Structure-based glycoengineering of interferon lambda 4 enhances its productivity and anti-viral potency |
Chung, Jae-Hee; Hong, Seon-Hui; Seo, Nari; Kim, Tae-Shin; An, Hyun Joo; Lee, Pedro; Shin, Eui-Cheol; Kim, Ho Min |
2020 |
2020-01-31 |
PMC |
N |
PMC7129780 |
31479875.0 |
10.1016/j.cyto.2019.154833 |
n8fzj661 |
0.529423 |
|
Sidhu_1996 |
| 13 |
Jalkanen_2020 |
Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung |
Juho Jalkanen; Ville Pettila; Matti Karvonen; Teppo Huttunen; Jami Mandelin; Markku Jalkanen; Markus Malmberg; Kati Elima; Geoff Bellingan; Maija Hollmen; Vito Marco Ranieri; Sirpa Jalkanen |
2020 |
2020-04-06 |
BioRxiv |
N |
|
|
10.1101/2020.04.01.20049700 |
p43v3ihz |
0.522362 |
Ban_J_2018, Pervolaraki_2017, Dixit_2013 |
Carrero_2013 |
| 14 |
Andreakos_2019 |
Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control |
Andreakos, Evangelos; Zanoni, Ivan; Galani, Ioanna E |
2019 |
2019-02-28 |
PMC |
N |
|
30399529.0 |
10.1016/j.coi.2018.10.007 |
322g5cl5 |
0.519929 |
Lester_2014, Dixit_2013, Bermejo-Jambrina_2018, Pervolaraki_2017 |
|
| 15 |
Bruening_2017 |
The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy |
Bruening, Janina; Weigel, Bettina; Gerold, Gisa |
2017 |
2017-02-01 |
COMM-USE |
N |
PMC5309426 |
28255563.0 |
10.1155/2017/7232361 |
2zi5iv2t |
0.486749 |
Dixit_2013, Lester_2014, Bermejo-Jambrina_2018 |
Egli_2014, Carrero_2013, Wong_2014 |
| 16 |
Selvaggi_2014 |
Interferon lambda 1–3 expression in infants hospitalized for RSV or HRV associated bronchiolitis |
Selvaggi, Carla; Pierangeli, Alessandra; Fabiani, Marco; Spano, Lucia; Nicolai, Ambra; Papoff, Paola; Moretti, Corrado; Midulla, Fabio; Antonelli, Guido; Scagnolari, Carolina |
2014 |
2014-05-31 |
PMC |
N |
|
24389019.0 |
10.1016/j.jinf.2013.12.010 |
n6jc0jy3 |
0.465021 |
Ban_J_2018, Zhu_Z_2018 |
|
| 17 |
Sorgeloos_2013 |
Antiviral Type I and Type III Interferon Responses in the Central Nervous System |
Sorgeloos, Frédéric; Kreit, Marguerite; Hermant, Pascale; Lardinois, Cécile; Michiels, Thomas |
2013 |
2013-03-15 |
COMM-USE |
N |
PMC3705299 |
23503326.0 |
10.3390/v5030834 |
6n5opf7l |
0.447386 |
Bermejo-Jambrina_2018, Dixit_2013, Lester_2014 |
|
| 18 |
Sprooten_2020 |
Chapter Three Type I interferons and endoplasmic reticulum stress in health and disease |
Sprooten, Jenny; Garg, Abhishek D. |
2020 |
2020-12-31 |
PMC |
N |
PMC7104985 |
32138904.0 |
10.1016/bs.ircmb.2019.10.004 |
gcjx8i14 |
0.440106 |
Dixit_2013, Lester_2014, Pervolaraki_2017 |
Carrero_2013, Peteranderl_2017 |
| 19 |
Lazear_2015 |
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond |
Lazear, Helen M.; Nice, Timothy J.; Diamond, Michael S. |
2015 |
2015-07-21 |
None |
N |
PMC4527169 |
26200010.0 |
10.1016/j.immuni.2015.07.001 |
s0bvpxtu |
0.438278 |
Lester_2014 |
Carrero_2013, Read_2019 |
| 20 |
Kelm_2016 |
The role of IL-29 in immunity and cancer |
Kelm, Noah E.; Zhu, Ziwen; Ding, Vivi A.; Xiao, Huaping; Wakefield, Mark R.; Bai, Qian; Fang, Yujiang |
2016 |
2016-10-31 |
PMC |
N |
PMC7129698 |
27637354.0 |
10.1016/j.critrevonc.2016.08.002 |
mwhdbw9q |
0.424680 |
|
|
| 21 |
Mahlakoiv_2012 |
P136 Combined action of type I and type III IFN restricts initial replication of SARS-coronavirus in the lung but fails to inhibit systemic virus spread |
Mahlakoiv, T.; Ritz, D.; Enjuanes, L.; Müller, M.A.; Drosten, C.; Staeheli, P. |
2012 |
2012-09-30 |
PMC |
N |
PMC7129343 |
|
10.1016/j.cyto.2012.06.228 |
02dsqbeg |
0.422270 |
|
Chen_2019 |
| 22 |
Wilkins_2012 |
IFITM1 is a tight junction protein that inhibits hepatitis C virus entry |
Wilkins, Courtney; Woodward, Jessica; Lau, Daryl T-Y; Barnes, Amy; Joyce, Michael; McFarlane, Nicola; McKeating, Jane; Tyrrell, D. Lorne; Gale, Michael |
2012 |
2012-12-12 |
None |
N |
PMC3566288 |
22996292.0 |
10.1002/hep.26066 |
f0x7nsz5 |
0.421782 |
Ban_J_2018, Dixit_2013, Meyerson_2017 |
|
| 23 |
Hong_2016 |
Interferon lambda 4 expression is suppressed by the host during viral infection |
Hong, MeeAe; Schwerk, Johannes; Lim, Chrissie; Kell, Alison; Jarret, Abigail; Pangallo, Joseph; Loo, Yueh-Ming; Liu, Shuanghu; Hagedorn, Curt H.; Gale, Michael; Savan, Ram |
2016 |
2016-11-14 |
NONCOMM |
N |
PMC5110018 |
27799623.0 |
10.1084/jem.20160437 |
czqw99kr |
0.414068 |
Ban_J_2018 |
Hamming_2013, Carrero_2013 |
| 24 |
Douam_2017 |
Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection In Vivo |
Douam, Florian; Soto Albrecht, Yentli E.; Hrebikova, Gabriela; Sadimin, Evita; Davidson, Christian; Kotenko, Sergei V.; Ploss, Alexander |
2017 |
2017-08-15 |
COMM-USE |
N |
PMC5559630 |
28811340.0 |
10.1128/mbio.00819-17 |
jlb0hwrg |
0.404685 |
Ban_J_2018, Dixit_2013, Swiecki_2010 |
Chen_2019, Carrero_2013 |
| 25 |
Berger_Rentsch_2011 |
A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon |
Berger Rentsch, Marianne; Zimmer, Gert |
2011 |
2011-10-05 |
COMM-USE |
N |
PMC3187809 |
21998709.0 |
10.1371/journal.pone.0025858 |
a8rkvaax |
0.384418 |
Ban_J_2018, Meyerson_2017 |
|
| 26 |
Syedbasha_2017 |
Interferon Lambda: Modulating Immunity in Infectious Diseases |
Syedbasha, Mohammedyaseen; Egli, Adrian |
2017 |
2017-02-28 |
COMM-USE |
N |
PMC5328987 |
28293236.0 |
10.3389/fimmu.2017.00119 |
p493tr5u |
0.382039 |
Lester_2014, Dixit_2013, Bermejo-Jambrina_2018 |
Egli_2014, Read_2019, Carrero_2013, O'Brien_2014 |
| 27 |
Egli_2014 |
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections |
Egli, Adrian; Santer, Deanna M; O'Shea, Daire; Tyrrell, D Lorne; Houghton, Michael |
2014 |
2014-07-16 |
COMM-USE |
N |
PMC4126180 |
26038748.0 |
10.1038/emi.2014.51 |
mz45gyyy |
0.374544 |
Lester_2014 |
Carrero_2013, Bruening_2017 |
| 28 |
de_Weerd_2012 |
The interferons and their receptors—distribution and regulation |
de Weerd, Nicole A; Nguyen, Thao |
2012 |
2012-03-13 |
PMC |
N |
PMC7165917 |
22410872.0 |
10.1038/icb.2012.9 |
l78k0xda |
0.372515 |
Lester_2014, Dixit_2013, Geijtenbeek_2009 |
|
| 29 |
Goldmann_2016 |
Fine-tuning of type I IFN-signaling in microglia — implications for homeostasis, CNS autoimmunity and interferonopathies |
Goldmann, Tobias; Blank, Thomas; Prinz, Marco |
2016 |
2016-02-29 |
PMC |
N |
PMC7126514 |
26397019.0 |
10.1016/j.conb.2015.09.003 |
wv2rnqyw |
0.364605 |
Dixit_2013, Pervolaraki_2017, López_2011, Lester_2014 |
Carrero_2013 |
| 30 |
Makris_2017 |
Type I Interferons as Regulators of Lung Inflammation |
Makris, Spyridon; Paulsen, Michelle; Johansson, Cecilia |
2017 |
2017-03-10 |
COMM-USE |
N |
PMC5344902 |
28344581.0 |
10.3389/fimmu.2017.00259 |
cdpjeahi |
0.352567 |
Lester_2014, Mao_J_2019, Bermejo-Jambrina_2018 |
Carrero_2013, Chen_2019 |
| 31 |
Mahlakõiv_2015 |
Leukocyte-Derived IFN-α/β and Epithelial IFN-λ Constitute a Compartmentalized Mucosal Defense System that Restricts Enteric Virus Infections |
Mahlakõiv, Tanel; Hernandez, Pedro; Gronke, Konrad; Diefenbach, Andreas; Staeheli, Peter |
2015 |
2015-04-07 |
COMM-USE |
N |
PMC4388470 |
25849543.0 |
10.1371/journal.ppat.1004782 |
y95g4354 |
0.340250 |
|
Read_2019, Solodova_2011 |
| 32 |
Lokugamage_2020 |
SARS-CoV-2 is sensitive to type I interferon pretreatment |
Kumari G. Lokugamage; Adam Hage; Craig Schindewolf; Ricardo Rajsbaum; Vineet D. Menachery |
2020 |
2020-03-09 |
BioRxiv |
Y |
|
|
10.1101/2020.03.07.982264 |
2w0zr9c0 |
0.310872 |
Ban_J_2018, Ashour_2010 |
|
| 33 |
Li_L_2019 |
IFN-Lambda 3 Mediates Antiviral Protection Against Porcine Epidemic Diarrhea Virus by Inducing a Distinct Antiviral Transcript Profile in Porcine Intestinal Epithelia |
Li, Liang; Xue, Mei; Fu, Fang; Yin, Lingdan; Feng, Li; Liu, Pinghuang |
2019 |
2019-10-17 |
COMM-USE |
N |
PMC6811514 |
31681286.0 |
10.3389/fimmu.2019.02394 |
86ksgl5t |
0.308647 |
Ban_J_2018 |
Chen_2019, Lee_S_2004 |